Tristel plc
("Tristel" or the "Company")
Update to Executive Performance Share Plan 2021
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the terms of the options to be granted under the rules of the Tristel plc Executive Performance Share Plan 2021 (the "Plan") to be put to shareholders for approval at the Annual General Meeting of the Company to be held on 10.00 a.m. on 15 December 2020 (the "AGM") will be amended to include more onerous performance targets for the vesting of the options.
A revised copy of Appendix I of the Notice of AGM summarising the principal terms of the Plan and of the options to be granted under the Plan and copies of the proposed option agreements incorporating, in each case, the more onerous performance targets, together with the full text of the Plan, the Notice of AGM and the Form of Proxy, are available for inspection on the Company's website at https://www.tristel.com/uk/investor-centre/agm-notices-proxies.
Any shareholder who wishes to change any proxy instructions already submitted, may do so by submitting a new proxy appointment using the methods set out in the notes to the Notice of AGM.
Shareholders are reminded that proxies must be received no later than 10.00 a.m. on 11 December 2020.
For further information please contact:
Tristel plc |
Tel: 01638 721 500 |
|
Paul Swinney, Chief Executive Officer |
|
|
Liz Dixon, Finance Director |
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Cawthorne |
Mob: 07584 391 303 |
|
|
|
|
finnCap |
Tel: 020 7220 0500 |
|
Geoff Nash/ Giles Rolls (Corporate Finance) |
|
|
Alice Lane (ECM) |
|
|